Neurotherapeutics

Neurotherapeutics is a quarterly peer-reviewed medical journal covering research on experimental treatments of neurological disorders. It was established in 2004 and is published by Springer Science+Business Media on behalf of the American Society for Experimental NeuroTherapeutics. The editor-in-chief is Maral Mouradian (Robert Wood Johnson Medical School). The founding editor-in-chief was Alan I. Faden (University of Maryland School of Medicine).

Neurotherapeutics
DisciplineNeurology
LanguageEnglish
Edited byMaral Mouradian
Publication details
History2004-present
Publisher
Springer Science+Business Media on behalf of the American Society for Experimental NeuroTherapeutics
FrequencyQuarterly
5.719 (2017)
Standard abbreviations
ISO 4Neurotherapeutics
Indexing
ISSN1933-7213 (print)
1878-7479 (web)
LCCN2006215616
OCLC no.82448136
Links

Abstracting and indexing

The journal is abstracted and indexed in:

According to the Journal Citation Reports, the journal has a 2017 impact factor of 5.719.[1]

gollark: Evolution tends to be quite thrifty. Why would I have significant general purpose cognitive resources only accessible in weird indirected ways?
gollark: Random online tests involving remembering sequences of shapes and stuff. Also the fact that I don't experience memories visually whatsoever.
gollark: So I could think abstractly about any problems I encounter, but that isn't much use.
gollark: And paper which randomly edits its contents isn't very useful.
gollark: Based on testing, I don't really have conscious access to any kind of working visual memory.

References
  1. "Neurotherapeutics". 2014 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2015.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.